Twist Bioscience Corp — Director's Dealing 2019

Oct 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2019-10-23

Reporting Person: Finn Patrick John (SVP, Commercial Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-23	Common Stock	S	26664	$23.0945	Disposed	12338	Direct
2019-10-23	Common Stock	S	100	$23.68	Disposed	12238	Direct
2019-10-24	Common Stock	S	6236	$22.4318	Disposed	6002	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2: Represents the aggregate of sales effected on the same day at different prices.

F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.67 to $23.60 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.24 to $23.11 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.